Daniel Patrick Godskesen True

Title: The Innovative Contributions of Daniel Patrick Godskesen True

Introduction

Daniel Patrick Godskesen True is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of drug delivery systems, holding a total of 2 patents. His work focuses on enhancing the efficiency and usability of medical devices, particularly in the realm of drug administration.

Latest Patents

One of his latest patents is a drug delivery device featuring a plunger rod with a nonuniform stopper interface. This invention provides a drug delivery device that includes a drug reservoir with an elastomeric stopper designed for optimal sealing interaction with the reservoir body. The plunger rod structure is engineered to displace the elastomeric stopper effectively, ensuring precise drug delivery.

Another significant patent is for an injection needle assembly designed for an injection device. This assembly includes a needle cannula attached to a needle hub, which defines a pointed tip at its free end. The needle cover is designed to axially collapse and become penetrated by the needle cannula when a penetration force is applied, enhancing the safety and functionality of the injection process.

Career Highlights

Daniel is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His role at Novo Nordisk allows him to apply his innovative ideas in a practical setting, contributing to advancements in medical technology.

Collaborations

Throughout his career, Daniel has collaborated with several talented individuals, including Modesto Javier Mora Benito and Soeren Kjellerup Hansen. These collaborations have fostered a creative environment that encourages the development of groundbreaking medical solutions.

Conclusion

Daniel Patrick Godskesen True's contributions to the field of drug delivery devices exemplify his commitment to innovation in healthcare. His patents reflect a deep understanding of the challenges in medical technology and a dedication to improving patient outcomes.